Predictors of Uncontrolled Blood Pressure in Treated Hypertensive Individuals: First Population-Based Study in Lebanon.

The Journal of Clinical Hypertension
Rita FarahHassan Hosseini

Abstract

Arterial hypertension is a leading risk factor for cardiovascular disease and stroke. This study aimed to assess the predictors of uncontrolled systolic and diastolic blood pressure (BP) in Lebanon among treated hypertensive individuals. The authors included 562 participants 40 years and older. The potential predictors included sociodemographic characteristics, self-reported health information, and medication adherence. Prevalence of uncontrolled systolic and diastolic BP reached 43.1% and 24.9%, respectively. Independent predictors of uncontrolled systolic BP were older age, male sex, and low and medium medication adherence level. Predictors of uncontrolled diastolic BP were younger age, obesity, and low medication adherence level. Married individuals and patients taking statins had better diastolic BP control. Uncontrolled BP is a major public health problem in Lebanon. The authors identified low adherence as a major modifiable risk factor for systolic and diastolic BP control and obesity as a major modifiable risk factor for diastolic BP control.

References

Dec 22, 1999·Archives of Internal Medicine·M AlexanderW Cooper
Oct 20, 2001·Hypertension·E L KnightJ Avorn
Apr 26, 2003·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Apr 22, 2004·Pharmacotherapy·Steven M OrnsteinLori M Dickerson
Sep 9, 2005·Journal of Hypertension·Bülent AltunUNKNOWN Turkish Society of Hypertension and Renal Diseases
Sep 15, 2005·Circulation·Thomas J Wang, Ramachandran S Vasan
Jan 26, 2011·Journal of Cardiovascular Disease Research·Manuel MorgadoMiguel Castelo-Branco
Sep 14, 2011·International Journal of Hypertension·Abdalla A SaeedLamiaa Z Abuzaid
Sep 22, 2011·ClinicoEconomics and Outcomes Research : CEOR·Luca Degli EspostiEzio Degli Esposti
Mar 14, 2012·BMC Cardiovascular Disorders·Renata PappSandor Balogh
May 23, 2013·QJM : Monthly Journal of the Association of Physicians·K MatsumuraUNKNOWN Comfort Investigators
Jul 31, 2013·The Journal of Clinical Hypertension·Gaurav J DaveLapronda Spann
Aug 6, 2013·Journal of the American Society of Hypertension : JASH·Doyle M CummingsPaul Muntner
Jan 7, 2014·Bulletin of the World Health Organization·Nayu IkedaStephen S Lim
Jan 27, 2015·The Journal of Clinical Hypertension·Dany MatarRabih R Azar

❮ Previous
Next ❯

Citations

Feb 15, 2018·Environmental Science and Pollution Research International·Pascale SalamehHassan Hosseiny
Jan 28, 2020·Cardiology in Review·Yara A JelwanFrancine K Welty
Jun 12, 2018·International Journal of Hypertension·R Bou SerhalN Saleh
Feb 8, 2019·International Journal of Hypertension·Aya NoubaniHussain Isma'eel
Aug 22, 2018·Health Services Insights·Hazar KanjAntoine Kossaify
Nov 24, 2017·The Journal of Clinical Hypertension·Francisco Flavio Costa FilhoAlvaro Avezum
Aug 18, 2017·British Journal of Clinical Pharmacology·Rosa L de JagerUNKNOWN SYMPATHY investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.